Instil Bio Q3 Adj EPS $(0.16) Misses $(0.10) Estimate
Portfolio Pulse from Benzinga Newsdesk
Instil Bio reported a Q3 EPS of $(0.52), a decrease from $(0.43) year-over-year, indicating a widening loss.
November 13, 2023 | 10:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Instil Bio's Q3 earnings report shows a larger year-over-year loss, with EPS falling to $(0.52) from $(0.43).
The reported increase in losses for Instil Bio is typically seen as a negative indicator for the company's financial health and may lead to a decrease in investor confidence, potentially impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100